Immune checkpoint inhibitors: A breakthrough for immunotherapy
Immune checkpoint inhibitors (ICIs) have shown their efficacy, not only as a standalone treatment, but also when combined with traditional methods like chemotherapy and radiation. However, persistent challenges such as high costs and regulatory hurdles still exist. Gain expert knowledge on this novel approach to cancer therapy, with key topics including:
Whitepaper Clinical Studies Pharmaceutical Research and Development
